Knowledge (XXG)

Malignancy

Source 📝

60: 1756: 1768: 552:
Lung cancer has the highest mortality rate in comparison to other forms of cancer, with the leading cause of development due to smoking. The number of smokers in China is rapidly increasing with tobacco killing approximately 3000 people each day. The diagnosis of lung cancer is most common within the
458:
Malignancy can be treated through the use of hyperthermia by applying either surgical perfusion or interstitial techniques to the body. The use of this treatment type largely depends on the fact that malignant and normal cells have differing responses to the energy source used. This dependency is due
388:
Surgery can help manage or treat malignancy by either removing the tumour, localising it and/or determining whether there has been a spread to other organs. When undertaking surgery for malignancy, there are six major objectives which are considered. These include "prevention of cancer, diagnosis and
313:
can also play a role in triggering malignancy as it can promote stages of tumour formation. The main purpose of inflammation is to repair tissue, defend the body against pathogens and regenerate cells. At the same time, inflammatory cells can also interact with malignant cells to form an inflammatory
266:
When malignant cells form, symptoms do not typically appear until there has been a significant growth of the mass. Once signs and symptoms do arise, they are dependent on the location, size and type of malignancy. Usually, it is quite general and can be associated with other illnesses or diseases and
423:(HPD) is a drug which was developed to be absorbed by malignant cells and only becomes active when exposed to light. It is commonly used to identify and localise cancers as when it is under activation of blue light the red fluorescence of the malignant tumour (due to the HPD) can be observed easily. 501:
which kill rapidly dividing cells within the body. It targets the cellular mechanisms which allow the development of malignancy throughout the body. There are no specific areas which are targeted and so, there is a lack of differentiation between normal and malignant cells, resulting in a range of
308:
have the ability to form an environment within states of chronic inflammation which gives rise to oncogenic potential. Viral agents are able to assist the formation of malignant tumours due to a mechanism of cell transformation. This cell transformation can occur through either "DNA integration or
548:
Malignancy has been a constant global health concern for a number of years, resulting in significant social and economic impacts on individuals with malignancy and their families. The risk of developing malignancy is 20.2%. In 2018, 18 million patients were diagnosed with a malignant tumour with
270:
Signs include observable or measurable aspects such as weight loss (without trying), a fever or unusual bleeding. On the other hand, symptoms are felt internally by the individual such as fatigue or changes in appetite. A general list of common signs and symptoms includes pain (headaches or bone
407:
Curative surgery (also known as primary surgery) can be conducted when the malignant tumour has only invaded one area of the body. The objective is to remove the entirety of the malignant cells without violating the tumour; if the tumour is violated, the risk of both tumour spillage and wound
257:
would then be required to make a diagnosis and distinguish whether the tumour is malignant or benign. This involves examination of a small sample of the tissue in a laboratory. If detected as a malignant tumour, treatment is necessary; treatment during early stages is most effective. Forms of
411:
The surgical procedure of tumour debulking can be undertaken to increase the effectiveness of postoperative forms of treatment. Symptom palliation and patient rehabilitation do not play a role in controlling or reducing malignancy growth rather, they increase the patient's quality of life.
404:. This process requires a sufficient amount of tissue to make a confident diagnosis and, the handling of specimen to expand information provided from testing. Biopsies are categorised into four different processes: "fine-needle aspirate (FNA), core needle, incisional and, excisional". 514:. Some side effects are specific to the anticancer drug used, the most common being bone marrow suppression as bone marrow has the ability to divide rapidly due to high growth fraction. This is because anticancer drugs have the highest activity in high growth fraction tissues. 351:". The different types of malignancy developed post-transplant depend on which organ was transplanted. This is linked to recipients being at a higher risk when exposed to traditional risk factors as well as, the type and intensity of the operation, the duration of their 560:
is the most frequent form of malignancy with the brain and nervous system subsequent. These individuals account for approximately 1% of the cancer mortality rate – about 110,000 children each year. In the 15–49-year-old age bracket the most common form of malignancy is
549:
lung, breast and prostate being the most common form. Additionally, there were approximately 10 million mortalities due to cancer in 2020 and, there is an overall trend which demonstrated that malignant mortality has increased by 28% over the past 15 years.
283:
Malignant cells often evolve due to a combination of reasons rather than one definitive reason. Reasons which can explain their development include genetics and family history, triggers such as infectious diseases, and exposure to risk factors.
210:
in more general medical use characterises a condition or growth that is not cancerous, i.e. does not spread to other parts of the body or invade nearby tissue. Sometimes the term is used to suggest that a condition is not dangerous or serious.
379:
are also used as treatment forms to kill or reduce malignant cells. A large portion of patients are at risk of death when diagnosed with malignancy as the disease has usually progressed for a number of years before detection.
330:
Traditional risk factors of developing malignancy include smoking, sun exposure and, having a history of cancer in the family. Other risk factors include developing post-transplant malignancy which occurs subsequent to solid
318:. This environment increases the likelihood of forming malignant cells through blockage of anti-tumour immunity. Once this occurs, the inflammatory tumour microenvironment begins to send out tumour-promoting signals to 438:
through the photodynamic process; where the oxygen molecule exists in an electronically excited state. The singlet oxygen is a cytotoxic agent which holds the ability to eradicate malignant cells by preventing both
392:
Surgical prevention of cancer largely consists of removing the organ at risk of developing malignancy. This would occur if an individual is predisposed to the formation of malignant cells as a result of inherited
295:
play a role in the development of malignancy, with agents of infectious disease being able to produce a multitude of malignant cells. These include bacterial causes, fungal and parasitic causes and, viral causes.
271:
aches), skin changes (new moles or bumps), coughing and unusual bleeding. There are also signs and symptoms specific to females including belly pain and bloating or breast changes i.e., the formation of a
471:
within each cell is affected indirectly and/or through multiple pathways. The combination of these intracellular changes means there is no specific target of cell death in the hyperthermic process.
482:
is commonly used as either the primary treatment or in conjunction with other treatment forms such as radiotherapy or surgery. It can be administered through "injection, intra-arterial (IA),
343:
Individuals who undergo organ transplant surgery have an increased risk of developing malignancy in comparison to the general population. The most common form of malignancy being "
524:
when reacting with DNA. This results in breaks within DNA strands causing either inter-strand or intra-strand DNA cross-linking. The sub-classes of alkylating agents are "
1590: 1265: 949: 199:
in that a malignancy is not self-limited in its growth, is capable of invading into adjacent tissues, and may be capable of spreading to distant tissues.
245:
Tumours can be detected through the visualisation or sensation of a lump on the body. In cases where there is no obvious representation of a lump, a
1221: 804: 447:. The treatment process also utilises HPD's capability of accumulating at higher levels in malignant tissues compared to most other tissues. 1392:
Papadimitraki ED, Bertsias G, Chamilos G, Boumpas DT (January 2011). "Systemic Lupus Erythematosus". Academic Press. pp. 1083–1108.
1351:
Hrycay EG, Bandiera SM (2015). "Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer". In Hardwick JP (ed.).
179: 'born') is the tendency of a medical condition to become progressively worse; the term is most familiar as a characterization of 450:
In the case of deeply pigmented or larger tumours, a stronger course of this treatment process is required in order to be effective.
1405: 1368: 1283: 1242: 673: 348: 1746: 1788: 426:
The combination of HPD with red light (photoradiation) has been used on various malignant tumours including malignant
315: 112:
Smoking, sun exposure, genetics - history of malignancy, solid organ transplantation (post-transplant malignancy),
27: 957: 626: 503: 344: 227: 234:, containing multiple subclones. They also frequently have reduced expression of DNA repair enzymes due to 1449:
Christophi C, Winkworth A, Muralihdaran V, Evans P (1998). "The treatment of malignancy by hyperthermia".
1138:"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit" 686: 645: 638: 135: 665: 332: 275:. Signs and symptoms specific to males include pain or growths in the scrotum or difficulty urinating. 230:, frequently have between 10,000 and 100,000 mutations in their entire genomes. Cancers usually show 231: 389:
staging of disease, disease cure, tumour debulking, symptom palliation and patient rehabilitation".
714: 292: 113: 258:
treatment include chemotherapy, surgery, photoradiation and hyperthermia, amongst various others.
1704: 1415: 1167: 1118: 773: 434:
on a range of different organs including the breast and colon. This form of treatment produces a
363:
There are various treatment forms available to help manage malignancy. Common treatments include
223: 94: 732: 1793: 1696: 1652: 1536: 1466: 1401: 1374: 1364: 1333: 1217: 1159: 1110: 1068: 1010: 900: 851: 800: 578: 525: 517: 444: 394: 352: 120: 82: 20: 1321: 1686: 1642: 1634: 1572: 1526: 1458: 1393: 1356: 1209: 1149: 1102: 1058: 1050: 1000: 890: 882: 841: 833: 507: 498: 1488: 1772: 1428: 755: 483: 420: 1320:
Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A (August 1978).
253:
can be used to determine the presence of a tumour. In the case of an existing tumour, a
1760: 1726: 1647: 1622: 1531: 1514: 1397: 1063: 1038: 895: 870: 846: 821: 652: 582: 435: 372: 168: 1462: 1204:
Donohue JH (2008). "Principles of cancer surgery.". In Norton JA, et al. (eds.).
1782: 1591:"Cancer data in Australia, cancer incidence and survival by stage data visualisation" 1154: 1137: 562: 521: 464: 460: 1171: 1122: 59: 928: 586: 566: 529: 479: 468: 440: 376: 364: 310: 203: 191: 139: 1708: 886: 99:
Fatigue, lump(s), change in skin, abnormal bleeding, prolonged cough, unexplained
1213: 1054: 837: 1576: 1360: 574: 570: 491: 487: 272: 246: 235: 107: 100: 1755: 1005: 988: 1638: 1106: 537: 533: 431: 319: 219: 1730: 1353:
Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer
553:
50–59-year age bracket. Further, it caused 1.8 million deaths in 2020 alone.
1722: 557: 427: 368: 305: 215: 72:) spreads uncontrollably and invades the surrounding tissues; benign tumor ( 1700: 1656: 1540: 1470: 1378: 1163: 1114: 1072: 1014: 904: 855: 520:
are used in chemotherapy as these are chemically reactive drugs which form
206:
has none of those properties, but may still be harmful to health. The term
1337: 593: 511: 297: 239: 87: 51: 659: 619: 355:
post-operation and, the risk of developing oncogenic viral infections.
1136:
Collett D, Mumford L, Banner NR, Neuberger J, Watson C (August 2010).
612: 459:
to the intracellular changes which occur during hyperthermia; as the
401: 254: 180: 125: 47: 1691: 1674: 301: 1093:
Rossi AP, Klein CL (February 2019). "Posttransplant Malignancy".
1039:"Inflammation and Cancer: Triggers, Mechanisms, and Consequences" 1322:"Photoradiation therapy for the treatment of malignant tumors" 250: 16:
Tendency of a medical condition to become progressively worse
871:"Intratumor heterogeneity: evolution through space and time" 633:
Non-oncologic disorders referred to as "malignant" include:
267:
thus, can be difficult to diagnose or can be misdiagnosed.
1355:. Advances in Pharmacology. Vol. 74. pp. 35–84. 987:
Callahan CM, Vincent AL, Greene JN, Sandin RL (May 1999).
573:
following. Finally, those aged 60 and over mainly develop
1563:
Lind MJ (2011). "Principles of cytotoxic chemotherapy".
1515:"Chemotherapy: managing side effects and safe handling" 799:. Lippincott Williams & Wilkins. pp. 858–869. 400:
Surgical diagnosis of malignancy involves completing a
1744: 795:
Wilkins EM (April 2008). "The Patient with Cancer".
322:
cells, triggering the formation of malignant cells.
309:
cellular-DNA alteration of growth regulator genes".
1260: 1258: 1256: 154: 146: 131: 119: 106: 93: 81: 43: 38: 1444: 1442: 1440: 1438: 950:"Signs and Symptoms of Cancer – Do I have cancer?" 797:Clinical Practice of the Dental Hygienist Workbook 1616: 1614: 1612: 1610: 1608: 1606: 1604: 1508: 1506: 1504: 1502: 1315: 1313: 1311: 1309: 1307: 1305: 76:) remains self-contained from neighbouring tissue 1489:"Chemotherapy: How it works and how you'll feel" 1482: 1480: 982: 980: 978: 976: 974: 528:, oxazaphosphorines, alkyl alkane, sulphonates, 26:"Malignant" redirects here. For other uses, see 1237: 1235: 1233: 1199: 1197: 1195: 1193: 1191: 1189: 1187: 1185: 1183: 1181: 1668: 1666: 1208:. New York, NY: Springer. pp. 1965–1984. 1032: 1030: 1028: 1026: 1024: 922: 920: 918: 916: 914: 1088: 1086: 1084: 1082: 708: 706: 704: 702: 222:. Malignant tumors are also characterized by 8: 1558: 1556: 1554: 1552: 1550: 1270:American Society of Clinical Oncology (ASCO) 1247:American Society of Clinical Oncology (ASCO) 954:American Society of Clinical Oncology (ASCO) 944: 942: 750: 748: 746: 238:methylation of DNA repair genes or altered 1595:Australian Institute of Health and Welfare 214:Malignancy in cancers is characterized by 58: 35: 1690: 1646: 1627:Journal of Epidemiology and Global Health 1530: 1153: 1062: 1004: 894: 845: 242:that control DNA repair gene expression. 929:"What are the different types of tumor?" 1751: 1675:"Epidemiology: The dominant malignancy" 1037:Greten FR, Grivennikov SI (July 2019). 698: 1621:Mattiuzzi C, Lippi G (December 2019). 1424: 1413: 497:The purpose of chemotherapy is to use 1095:The Surgical Clinics of North America 190:tumor contrasts with a non-cancerous 7: 1142:American Journal of Transplantation 1398:10.1016/B978-0-12-374994-9.10058-0 226:, so that cancers, as assessed by 14: 1266:"How Surgery Is Used for Cancer?" 989:"Infectious Causes of Malignancy" 820:Tuna M, Amos CI (November 2013). 1766: 1754: 1155:10.1111/j.1600-6143.2010.03181.x 663:(malaria caused specifically by 1519:The Canadian Veterinary Journal 760:World Health Organization (WHO) 375:procedures. Photoradiation and 1487:Nazzario B (8 February 2021). 1288:NCI Dictionary of Cancer Terms 822:"Genomic sequencing in cancer" 674:Neuroleptic malignant syndrome 1: 1623:"Current Cancer Epidemiology" 1463:10.1016/s0960-7404(99)00007-9 887:10.1158/0008-5472.CAN-12-2217 556:In those aged 14 or younger, 408:implantation would increase. 349:lymphoproliferative disorders 1284:"Hematoporphyrin derivative" 1214:10.1007/978-0-387-68113-9_95 1055:10.1016/j.immuni.2019.06.025 927:Brazier Y (21 August 2019). 838:10.1016/j.canlet.2012.11.004 502:side effects. This includes 1673:Bender E (September 2014). 1577:10.1016/j.mpmed.2011.09.009 1361:10.1016/bs.apha.2015.03.003 776:. Mount Sinai Health System 737:National Cancer Institution 150:442.4 per 100,000 per year 1810: 1006:10.1177/107327489900600314 869:Swanton C (October 2012). 421:Hematoporphyrin derivative 339:Post-transplant malignancy 175: 'badly' and 28:Malignant (disambiguation) 25: 18: 1639:10.2991/jegh.k.191008.001 1513:MacDonald V (June 2009). 1243:"What is cancer surgery?" 1107:10.1016/j.suc.2018.09.004 660:Malignant tertian malaria 66: 57: 653:Malignant otitis externa 627:Malignant transformation 494:(IV), topical or oral". 397:and, acquired diseases. 592:Uses of "malignant" in 504:bone marrow suppression 345:nonmelanoma skin cancer 228:whole genome sequencing 687:Precancerous condition 646:Malignant hyperthermia 639:Malignant hypertension 333:organ transplantations 136:Photoradiation therapy 1493:WebMD – Cancer Centre 719:WebMD – Cancer Centre 666:Plasmodium falciparum 158:~10 million per year 774:"Benign Information" 762:. 21 September 2021. 611:are synonymous with 347:and, posttransplant 232:tumour heterogeneity 218:, invasiveness, and 1789:Medical terminology 733:"Cancer statistics" 293:Infectious diseases 114:infectious diseases 933:Medical News Today 713:Martin LJ (2020). 605:malignant neoplasm 262:Signs and symptoms 224:genome instability 19:For the band, see 1735:Our World in Data 1451:Surgical Oncology 1423:Missing or empty 1223:978-0-387-30800-5 881:(19): 4875–4882. 806:978-1-58255-838-7 715:"Cancer Symptoms" 526:nitrogen mustards 518:Alkylating agents 445:protein synthesis 395:genetic mutations 353:immunosuppression 162: 161: 121:Diagnostic method 68:Malignant tumor ( 33:Medical condition 21:Malignancy (band) 1801: 1771: 1770: 1769: 1759: 1758: 1750: 1739: 1738: 1719: 1713: 1712: 1694: 1670: 1661: 1660: 1650: 1618: 1599: 1598: 1587: 1581: 1580: 1560: 1545: 1544: 1534: 1510: 1497: 1496: 1484: 1475: 1474: 1446: 1433: 1432: 1426: 1421: 1419: 1411: 1389: 1383: 1382: 1348: 1342: 1341: 1332:(8): 2628–2635. 1317: 1300: 1299: 1297: 1295: 1280: 1274: 1273: 1262: 1251: 1250: 1249:. 31 March 2011. 1239: 1228: 1227: 1201: 1176: 1175: 1157: 1148:(8): 1889–1896. 1133: 1127: 1126: 1090: 1077: 1076: 1066: 1034: 1019: 1018: 1008: 984: 969: 968: 966: 965: 956:. Archived from 946: 937: 936: 924: 909: 908: 898: 866: 860: 859: 849: 817: 811: 810: 792: 786: 785: 783: 781: 770: 764: 763: 752: 741: 740: 729: 723: 722: 710: 508:gastrointestinal 499:cytotoxic agents 316:microenvironment 77: 62: 36: 1809: 1808: 1804: 1803: 1802: 1800: 1799: 1798: 1779: 1778: 1777: 1767: 1765: 1753: 1745: 1743: 1742: 1721: 1720: 1716: 1685:(7517): S2–S3. 1672: 1671: 1664: 1620: 1619: 1602: 1589: 1588: 1584: 1571:(12): 711–716. 1562: 1561: 1548: 1512: 1511: 1500: 1486: 1485: 1478: 1448: 1447: 1436: 1422: 1412: 1408: 1391: 1390: 1386: 1371: 1350: 1349: 1345: 1326:Cancer Research 1319: 1318: 1303: 1293: 1291: 1282: 1281: 1277: 1264: 1263: 1254: 1241: 1240: 1231: 1224: 1203: 1202: 1179: 1135: 1134: 1130: 1092: 1091: 1080: 1036: 1035: 1022: 986: 985: 972: 963: 961: 948: 947: 940: 926: 925: 912: 875:Cancer Research 868: 867: 863: 819: 818: 814: 807: 794: 793: 789: 779: 777: 772: 771: 767: 754: 753: 744: 739:. 2 April 2015. 731: 730: 726: 712: 711: 700: 695: 683: 609:malignant tumor 546: 484:intraperitoneal 477: 456: 418: 386: 361: 341: 328: 290: 281: 264: 67: 34: 31: 24: 17: 12: 11: 5: 1807: 1805: 1797: 1796: 1791: 1781: 1780: 1776: 1775: 1763: 1741: 1740: 1714: 1692:10.1038/513S2a 1662: 1633:(4): 217–222. 1600: 1582: 1546: 1525:(6): 665–668. 1498: 1476: 1457:(1–2): 83–90. 1434: 1406: 1384: 1369: 1343: 1301: 1275: 1252: 1229: 1222: 1177: 1128: 1078: 1020: 999:(3): 294–300. 993:Cancer Control 970: 938: 910: 861: 832:(2): 161–170. 826:Cancer Letters 812: 805: 787: 765: 742: 724: 697: 696: 694: 691: 690: 689: 682: 679: 678: 677: 670: 656: 649: 642: 631: 630: 623: 615: 545: 542: 522:covalent bonds 476: 473: 455: 452: 436:singlet oxygen 417: 416:Photoradiation 414: 385: 382: 360: 357: 340: 337: 327: 324: 289: 286: 280: 277: 263: 260: 160: 159: 156: 152: 151: 148: 144: 143: 142:, hyperthermia 133: 129: 128: 123: 117: 116: 110: 104: 103: 97: 91: 90: 85: 79: 78: 64: 63: 55: 54: 45: 41: 40: 32: 15: 13: 10: 9: 6: 4: 3: 2: 1806: 1795: 1792: 1790: 1787: 1786: 1784: 1774: 1764: 1762: 1757: 1752: 1748: 1736: 1732: 1728: 1724: 1718: 1715: 1710: 1706: 1702: 1698: 1693: 1688: 1684: 1680: 1676: 1669: 1667: 1663: 1658: 1654: 1649: 1644: 1640: 1636: 1632: 1628: 1624: 1617: 1615: 1613: 1611: 1609: 1607: 1605: 1601: 1596: 1592: 1586: 1583: 1578: 1574: 1570: 1566: 1559: 1557: 1555: 1553: 1551: 1547: 1542: 1538: 1533: 1528: 1524: 1520: 1516: 1509: 1507: 1505: 1503: 1499: 1494: 1490: 1483: 1481: 1477: 1472: 1468: 1464: 1460: 1456: 1452: 1445: 1443: 1441: 1439: 1435: 1430: 1417: 1409: 1407:9780123749949 1403: 1399: 1395: 1388: 1385: 1380: 1376: 1372: 1370:9780128031193 1366: 1362: 1358: 1354: 1347: 1344: 1339: 1335: 1331: 1327: 1323: 1316: 1314: 1312: 1310: 1308: 1306: 1302: 1289: 1285: 1279: 1276: 1271: 1267: 1261: 1259: 1257: 1253: 1248: 1244: 1238: 1236: 1234: 1230: 1225: 1219: 1215: 1211: 1207: 1200: 1198: 1196: 1194: 1192: 1190: 1188: 1186: 1184: 1182: 1178: 1173: 1169: 1165: 1161: 1156: 1151: 1147: 1143: 1139: 1132: 1129: 1124: 1120: 1116: 1112: 1108: 1104: 1100: 1096: 1089: 1087: 1085: 1083: 1079: 1074: 1070: 1065: 1060: 1056: 1052: 1048: 1044: 1040: 1033: 1031: 1029: 1027: 1025: 1021: 1016: 1012: 1007: 1002: 998: 994: 990: 983: 981: 979: 977: 975: 971: 960:on 2020-11-30 959: 955: 951: 945: 943: 939: 934: 930: 923: 921: 919: 917: 915: 911: 906: 902: 897: 892: 888: 884: 880: 876: 872: 865: 862: 857: 853: 848: 843: 839: 835: 831: 827: 823: 816: 813: 808: 802: 798: 791: 788: 775: 769: 766: 761: 757: 751: 749: 747: 743: 738: 734: 728: 725: 720: 716: 709: 707: 705: 703: 699: 692: 688: 685: 684: 680: 676: 675: 671: 668: 667: 662: 661: 657: 655: 654: 650: 648: 647: 643: 641: 640: 636: 635: 634: 629: 628: 624: 622: 621: 616: 614: 610: 606: 602: 599: 598: 597: 595: 590: 588: 584: 580: 576: 572: 568: 564: 563:breast cancer 559: 554: 550: 543: 541: 539: 535: 531: 527: 523: 519: 515: 513: 510:problems and 509: 505: 500: 495: 493: 489: 485: 481: 474: 472: 470: 466: 465:cell membrane 462: 461:nucleic acids 453: 451: 448: 446: 442: 437: 433: 429: 424: 422: 415: 413: 409: 405: 403: 398: 396: 390: 383: 381: 378: 374: 370: 366: 358: 356: 354: 350: 346: 338: 336: 334: 325: 323: 321: 317: 312: 307: 303: 299: 294: 287: 285: 278: 276: 274: 268: 261: 259: 256: 252: 248: 243: 241: 237: 233: 229: 225: 221: 217: 212: 209: 205: 200: 198: 196: 195: 189: 184: 182: 178: 174: 170: 166: 157: 153: 149: 145: 141: 137: 134: 130: 127: 124: 122: 118: 115: 111: 109: 105: 102: 98: 96: 92: 89: 86: 84: 80: 75: 71: 65: 61: 56: 53: 49: 46: 42: 37: 29: 22: 1734: 1717: 1682: 1678: 1630: 1626: 1594: 1585: 1568: 1564: 1522: 1518: 1492: 1454: 1450: 1425:|title= 1387: 1352: 1346: 1329: 1325: 1292:. Retrieved 1287: 1278: 1269: 1246: 1205: 1145: 1141: 1131: 1101:(1): 49–64. 1098: 1094: 1049:(1): 27–41. 1046: 1042: 996: 992: 962:. Retrieved 958:the original 953: 932: 878: 874: 864: 829: 825: 815: 796: 790: 778:. Retrieved 768: 759: 736: 727: 718: 672: 664: 658: 651: 644: 637: 632: 625: 617: 608: 604: 600: 591: 589:malignancy. 555: 551: 547: 544:Epidemiology 530:nitrosoureas 516: 496: 480:Chemotherapy 478: 475:Chemotherapy 469:cytoskeleton 457: 454:Hyperthermia 449: 441:nucleic acid 425: 419: 410: 406: 399: 391: 387: 377:hyperthermia 365:chemotherapy 362: 342: 329: 326:Risk factors 311:Inflammation 304:and similar 291: 282: 269: 265: 244: 213: 207: 204:benign tumor 201: 193: 192: 187: 185: 176: 172: 164: 163: 140:chemotherapy 108:Risk factors 73: 69: 50:, malignant 571:lung cancer 492:intravenous 488:intrathecal 138:, surgery, 101:weight loss 44:Other names 1783:Categories 964:2021-05-31 693:References 618:Malignant 601:Malignancy 579:colorectal 538:aziridines 534:tetrazines 432:carcinomas 359:Management 320:epithelial 236:epigenetic 220:metastasis 167:(from 165:Malignancy 39:Malignancy 1727:Ritchie H 1416:cite book 596:include: 558:leukaemia 428:melanomas 369:radiation 306:pathogens 247:mammogram 240:microRNAs 216:anaplasia 188:malignant 147:Frequency 132:Treatment 83:Specialty 1794:Oncology 1773:Medicine 1731:"Cancer" 1729:(2015). 1701:25208070 1657:31854162 1565:Medicine 1541:19721789 1471:10421511 1379:26233903 1294:23 April 1172:40192165 1164:20659094 1123:53756320 1115:30471741 1073:31315034 1043:Immunity 1015:10758560 905:23002210 856:23178448 756:"Cancer" 681:See also 594:oncology 512:alopecia 373:surgical 298:Bacteria 288:Triggers 251:MRI test 95:Symptoms 88:Oncology 52:neoplasm 1761:Biology 1747:Portals 1723:Roser M 1648:7310786 1532:2684058 1206:Surgery 1064:6831096 896:3712191 847:3622788 620:ascites 583:stomach 384:Surgery 314:tumour 1709:577152 1707:  1699:  1679:Nature 1655:  1645:  1539:  1529:  1469:  1404:  1377:  1367:  1338:667856 1336:  1290:. 2021 1220:  1170:  1162:  1121:  1113:  1071:  1061:  1013:  903:  893:  854:  844:  803:  780:23 May 613:cancer 490:(IT), 486:(IP), 402:biopsy 279:Causes 255:biopsy 249:or an 208:benign 194:benign 181:cancer 155:Deaths 126:Biopsy 48:Cancer 1705:S2CID 1168:S2CID 1119:S2CID 587:liver 567:liver 565:with 302:fungi 197:tumor 177:-gnus 171: 169:Latin 70:right 1697:PMID 1653:PMID 1537:PMID 1467:PMID 1429:help 1402:ISBN 1375:PMID 1365:ISBN 1334:PMID 1296:2021 1218:ISBN 1160:PMID 1111:PMID 1069:PMID 1011:PMID 901:PMID 852:PMID 801:ISBN 782:2023 607:and 585:and 575:lung 569:and 536:and 467:and 443:and 430:and 371:and 273:lump 173:male 74:left 1687:doi 1683:513 1643:PMC 1635:doi 1573:doi 1527:PMC 1459:doi 1394:doi 1357:doi 1210:doi 1150:doi 1103:doi 1059:PMC 1051:doi 1001:doi 891:PMC 883:doi 842:PMC 834:doi 830:340 540:." 1785:: 1733:. 1725:; 1703:. 1695:. 1681:. 1677:. 1665:^ 1651:. 1641:. 1629:. 1625:. 1603:^ 1593:. 1569:39 1567:. 1549:^ 1535:. 1523:50 1521:. 1517:. 1501:^ 1491:. 1479:^ 1465:. 1453:. 1437:^ 1420:: 1418:}} 1414:{{ 1400:. 1373:. 1363:. 1330:38 1328:. 1324:. 1304:^ 1286:. 1268:. 1255:^ 1245:. 1232:^ 1216:. 1180:^ 1166:. 1158:. 1146:10 1144:. 1140:. 1117:. 1109:. 1099:99 1097:. 1081:^ 1067:. 1057:. 1047:51 1045:. 1041:. 1023:^ 1009:. 995:. 991:. 973:^ 952:. 941:^ 931:. 913:^ 899:. 889:. 879:72 877:. 873:. 850:. 840:. 828:. 824:. 758:. 745:^ 735:. 717:. 701:^ 603:, 581:, 577:, 532:, 506:, 463:, 367:, 335:. 300:, 202:A 186:A 183:. 1749:: 1737:. 1711:. 1689:: 1659:. 1637:: 1631:9 1597:. 1579:. 1575:: 1543:. 1495:. 1473:. 1461:: 1455:7 1431:) 1427:( 1410:. 1396:: 1381:. 1359:: 1340:. 1298:. 1272:. 1226:. 1212:: 1174:. 1152:: 1125:. 1105:: 1075:. 1053:: 1017:. 1003:: 997:6 967:. 935:. 907:. 885:: 858:. 836:: 809:. 784:. 721:. 669:) 30:. 23:.

Index

Malignancy (band)
Malignant (disambiguation)
Cancer
neoplasm

Specialty
Oncology
Symptoms
weight loss
Risk factors
infectious diseases
Diagnostic method
Biopsy
Photoradiation therapy
chemotherapy
Latin
cancer
benign tumor
benign tumor
anaplasia
metastasis
genome instability
whole genome sequencing
tumour heterogeneity
epigenetic
microRNAs
mammogram
MRI test
biopsy
lump

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.